期刊文献+

葛根黄酮自微乳化软胶囊的制备和溶出度的考察 被引量:11

Preparation of self-microemulsifying soft capsule and investigation of dissolution for pueraria lobata isoflavone
下载PDF
导出
摘要 目的:研制葛根黄酮自微乳化软胶囊,并考察其溶出度。方法:通过溶解度实验,三元相图的绘制,体外乳化和稳定性实验确定最佳处方;以市售愈风宁心片为参比制剂测定自微乳化软胶囊(SMESC)的溶出度。结果:该自微乳化软胶囊中的乳化剂为聚山梨酯-80,助乳化剂为1,2-丙二醇,油相为油酸乙酯,其比例为65∶20∶15。SMESC在水、pH6.8缓冲液和0.1mol/L盐酸中,10min的溶出度可达90以上,而愈风宁心片90min的溶出度不足40。结论:葛根黄酮自微乳化软胶囊与市售片剂相比,其在水、人工肠液和人工胃液中的溶出度显著提高。 AIM: In order to prepare the self-microemulsifying soft capsule (SMESC)of pueraria lobata isoflavone and investigate its dissolution property. METHODS: Through solubility experiment, self-microemulsification in vitro, phase diagram and the stability of solution, the optimum formulation was selected for pueraria lobata isoflavone. The dissolution of SMESC was measured taking the commercial tablet as reference. RESULTS : In the selected formulation, Tween-80, 1,2-Propanediol and ethyl oleate were screened as emulsifier, co-emulsifier and oil phase,respectively. The optimized proportion was 65: 20: 15 . The dissolution of SMESC in the condition of distilled water,pH6.8 phosphate buffer and 0. 1 mol/L HCl were more than 90% in 10 min,while those of the commercial tablet were less than 40% in 90 min. CONCLUSION : In comparison with the commercial tablet, the dissolution of pueraria lobata isoflavone is sufficiently improved at various conditions.
出处 《中成药》 CAS CSCD 北大核心 2007年第7期993-996,共4页 Chinese Traditional Patent Medicine
关键词 葛根黄酮 自微乳化软胶囊 溶出度 pueraria lobata isoflavone selfmicroemulsifying soft capsule dissolution.
  • 相关文献

参考文献10

  • 1中国药典2005年版[S].2005.附录XF76.
  • 2Itoh K,Tozuka Y,Oguehi T,et al.Improvement of physicochemical properties of N-4472 part I formulation design by using selfmicroemulsifying system[J].Int J Pharm,2002,238:153-160.
  • 3Shall NH,Carvajal MT,Patel CI,et al.Self-emulsifying drug delivery systems(SEDDS)with polyglyeolzed glycerides for:improving in vitro dissolution and oral absorption of lipophilie drugs[J].Int J Pharm,1994,106(1):15-23.
  • 4Gershanik T,Benzeno S,Benita S.Interaction of the self-emulsifying lipid drug delivery system with mueosa of everted rat intestine as a function of surface charge and droplet size[J].Pharm Res,1998,15(6):863-870.
  • 5Pouton CW.Self-emulsifying drug dehvery systems:assessment of the efficiency of emulsification[J].Int J Pharm,1985,27:335-342.
  • 6Chamman SS,Charman WN,Rogge MC,et al.Self-emulsifying drug dehvery systems:formulation and biopharmaceutic evaluation of an investigation lipophilic compound[J].Pharm Res,1992,9(1):87-93.
  • 7Shui-Me:Khoo,Andrew JH,et al.Formulahion design and bioavailability assessment of lipdic self-emulsifying formulations of halofantrine[J].Int J Pharm,1998,167:155-164.
  • 8Kommuru TR,Gufley B,Khan MA,et al.Self-emulsifying drug dehvery systems(SEDDS)of coenzyme Q10:formulation development and bioavailability assessment[J].Int J,Pharm,2001,212(1):233-246.
  • 9Craig DQM,Barker SA,Banning D,et al.An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy[J].Int J Pharm,1995,114(1):103-110.
  • 10Bachynsky MO,Shah NH,Patel CI,et al.Factors affecting the effciency of a self-emulsifying oral delivery system[J].Drug Dev Ind Pharm,1997,23(8):809-814.

共引文献34

同被引文献118

引证文献11

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部